• HOME
  • QUIZ
  • CONTACT US
EXAMIANS
  • COMPUTER
  • CURRENT AFFAIRS
  • ENGINEERING
    • Chemical Engineering
    • Civil Engineering
    • Computer Engineering
    • Electrical Engineering
    • Mechanical Engineering
  • ENGLISH GRAMMAR
  • GK
  • GUJARATI MCQ

Current Affairs - July 2020

Current Affairs - July 2020
Name the group which has launched the generic Favipiravir in India under the brand 'Favivir' in India to treat Covid-19 infected patients.

Cipla
Lupin
Sun
Hetero

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
Which country has formally notified the United Nations of its decision of withdrawal from the global health body WHO?

India
United States of America
Germany
France

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
India and which country have signed an agreement to further expand their collaboration in dealing with cyber threats?

Israel
Germany
Russia
Brazil

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
NABARD has provided credit support of Rs 1,607 crore to which state during the COVID-19 pandemic?

Maharashtra
Jharkhand
Bihar
West Bengal

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
TRIFED has entered into a partnership with which IIT for the Unnat Bharat Abhiyan (UBA)?

IIT Bangalore
IIT Mumbai
IIT Roorkee
IIT Delhi

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
Edelweiss Asset Management Company, a subsidiary of Edelweiss Capital Limited has decided to bring the second installment of the Bharat Bond ETF with two new series to raise how much fund in July 2020?

Rs 4,000 crore
Rs 14,000 crore
Rs 16,000 crore
Rs 24,000 crore

ANSWER DOWNLOAD EXAMIANS APP
MORE MCQ ON Current Affairs - July 2020

DOWNLOAD APP

  • APPLE
    from app store
  • ANDROID
    from play store

SEARCH

LOGIN HERE


  • GOOGLE

FIND US

  • 1.70K
    FOLLOW US
  • EXAMIANSSTUDY FOR YOUR DREAMS.
  • SUPPORT :SUPPORT EMAIL ACCOUNT : examians@yahoo.com

OTHER WEBSITES

  • GUJARATI MCQ
  • ACCOUNTIANS

QUICK LINKS

  • HOME
  • QUIZ
  • PRIVACY POLICY
  • DISCLAIMER
  • TERMS & CONDITIONS
  • CONTACT US
↑